Video

Emerging Treatment Options for Patients with HER2+ Metastatic Colorectal Cancer

Discussion centered around emerging treatment options for patients with HER2+ mCRC, including trastuzumab deruxtucan.

Video Player is loading.
Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
  • Chapters
  • descriptions off, selected
  • captions off, selected

    Related Content